Sign In

Press release centre

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

Past Press Releases - Affimed Therapeutics AG

June 5, 2008
Affimed appoints Chief Business Officer
Affimed Therapeutics AG, a biopharmaceutical company focused on the development of antibody therapeutics, today announced that it has appointed Volker Lang, Ph.D., as its Chief Business Officer. More

May 13, 2008
Affimed validates antibody target for cancer metastasis
Affimed Therapeutics AG, a biopharmaceutical company focused on the development of antibody therapeutics, announced today that a collaboration with Dr. Stefan Weiss at the Institute of Biochemistry of the Ludwig Maximilian University in Munich has strongly validated a target for cancer metastases amenable to the development of antibodies or other therapeutic interventions. More

April 4, 2007
Affimed Closes € 25 MM (US $ 32 MM) Series B financing
HEIDELBERG, Germany - April 4, 2007 - Affimed Therapeutics, AG, a leading developer of next generation antibody therapeutics, announced today the closing of a 25 million (US $ 32 million) Series B financing to enable the Company to fund the clinical development of its lead products.

October 2, 2006
XOMA and Affimed Sign Antibody Cross-License and Collaboration Agreement
XOMA Ltd. and Affimed Therapeutics AG have signed a cross-license and collaboration agreement for antibody-related technologies. More


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Dec 6€9.3MSoftware development
Dec 6€1.5MConsumer applications
Dec 6€3.7MInternet commerce
Dec 5€8.0MNanotechnology
Dec 5€11.0MBiotechnology
Dec 5€11.0MRobotics
Dec 5N/ARobotics

For information on Europe's most extensive database on technology funding click here!


Press Releases

May 28
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises 1m in seed funding to build tech-enabled home ...

About usContact usLegal Information
Copyright 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.